Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy

Area of Science:

• Oncology
• Immunology
• Nanotechnology
• Biomaterials

Background:

• Tumor immunotherapy is a key precision medicine strategy, but often fails due to the immunosuppressive tumor microenvironment and heterogeneity.
• Understanding the tumor immune microenvironment and immune escape mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

• To review the relationship between tumors and their immune microenvironment, and mechanisms of tumor immune escape.
• To introduce various immunotherapy classifications and highlight the role of biomimetic nanodelivery systems.
• To discuss recent advances, applications, challenges, and future perspectives of biomimetic nanodelivery systems in tumor immunotherapy.

Main Methods:

• Literature review and summary of existing research on tumor immunotherapy and nanodelivery systems.
• Categorization of immunotherapy approaches, including adoptive cellular therapy, cytokines, cancer vaccines, and immune checkpoint inhibitors.
• Detailed introduction to biomimetic nanodelivery systems utilizing immune cells, erythrocytes, tumor cells, platelets, and bacteria.

Main Results:

• Biomimetic nanodelivery systems show potential to improve immunotherapy efficacy by targeting tumor sites and reducing off-target effects.
• Various biomimetic materials are being explored for their ability to enhance drug delivery and immune response modulation.
• Specific applications of biomimetic nanodelivery systems in conjunction with tumor vaccines are also reviewed.

Conclusions:

• Biomimetic nanodelivery systems represent a significant advancement in overcoming the limitations of current tumor immunotherapy.
• Further research and development are needed to address challenges and fully realize the potential of these systems for cancer treatment.